Munafa Stock Market Course + Intraday & FNO calls 
Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Seres Therapeutics (MCRB)
Technical Analysis Report for USA stock MCRB Seres Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock MCRB Seres Therapeutics then click here. or read Experts views on Seres Therapeutics or Forecast & share price targets of Seres Therapeutics
Seres Therapeutics Opened at 2.91 and Closed at: 2.85, which is -3.16% of previous session's close. It moved within a range of 2.81 and 2.91
The session was a Bearish session with an average volume of 63300, which is -59.4% of previous session's volumes.
- The stock has fallen, and its short term trend is also negative and in a downtrend.
- The stock has fallen, and its mid term trend is also negative and in a downtrend.
- The stock has fallen, and its long term trend is also negative and in a downtrend.
Support for tomorrow is 2.78 and resistance for tomorrow is 2.88
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 2.8, 2.76 resistance for tomorrow's hourly charts is 2.9, 2.96
10 Day SMA for Seres Therapeutics (MCRB) is 3.4 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Seres Therapeutics (MCRB) is 4.03 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Seres Therapeutics (MCRB) is 4.54 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 5.62 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Seres Therapeutics is 8.28 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Seres Therapeutics is at 4.03 and 200 DMA is at 8.28, while 50 DMA and 100 DMA are at 4.54 and 5.62 respectively
Seres Therapeutics (MCRB) moving average of 20 SMA is at 4.03 and 20 EMA is at 3.84
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 2.85 | 4.03 | 3.84 |
| 02 Fri Oct | 2.94 | 4.18 | 3.94 |
| 01 Thu Oct | 2.93 | 4.31 | 4.04 |
| 30 Wed Sep | 3.35 | 4.44 | 4.16 |
| 29 Tue Sep | 3.48 | 4.53 | 4.24 |
| 28 Mon Sep | 3.52 | 4.61 | 4.32 |
Seres Therapeutics (MCRB) moving average of 50 SMA is at 4.54 and 50 EMA is at 4.56
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 2.85 | 4.54 | 4.56 |
| 02 Fri Oct | 2.94 | 4.58 | 4.63 |
| 01 Thu Oct | 2.93 | 4.62 | 4.7 |
| 30 Wed Sep | 3.35 | 4.67 | 4.77 |
| 29 Tue Sep | 3.48 | 4.71 | 4.83 |
| 28 Mon Sep | 3.52 | 4.74 | 4.89 |
Seres Therapeutics (MCRB) moving average of 100 SMA is at 5.62 and 100 EMA is at 5.71
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 2.85 | 5.62 | 5.71 |
| 02 Fri Oct | 2.94 | 5.67 | 5.77 |
| 01 Thu Oct | 2.93 | 5.72 | 5.83 |
| 30 Wed Sep | 3.35 | 5.77 | 5.89 |
| 29 Tue Sep | 3.48 | 5.82 | 5.94 |
| 28 Mon Sep | 3.52 | 5.86 | 5.99 |
Seres Therapeutics (MCRB) moving average of 200 SMA is at 8.28 and 200 EMA is at 7.31
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 2.85 | 8.28 | 7.31 |
| 02 Fri Oct | 2.94 | 8.34 | 7.36 |
| 01 Thu Oct | 2.93 | 8.41 | 7.4 |
| 30 Wed Sep | 3.35 | 8.47 | 7.45 |
| 29 Tue Sep | 3.48 | 8.54 | 7.49 |
| 28 Mon Sep | 3.52 | 8.61 | 7.53 |
Urogen Pharma has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Urogen Pharma, about 46.37% more returns!
Trinity Biotech has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Trinity Biotech, about 12.43% more returns!
Savara Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Savara Inc, about 35.18% more returns!
Solid Biosciences has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Solid Biosciences, about 19.84% more returns!
Seres Therapeutics has performed better than Uniqure N in short term. Holding Seres Therapeutics could be a better choice for now!
Mannkind Corporation has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Mannkind Corporation, about 40.57% more returns!
Microbot Medical has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Microbot Medical, about 21.41% more returns!
Kala Pharmaceuticals has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Kala Pharmaceuticals, about 15.41% more returns!
Evolus Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Evolus Inc, about 32.86% more returns!
Dare Bioscience has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 67.05% more returns!
Collplant Holdings has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Collplant Holdings, about 43.99% more returns!
Chemocentryx Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Chemocentryx Inc, about 37.49% more returns!
Beyondspring Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Beyondspring Inc, about 76.16% more returns!
Anavex Life has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Anavex Life, about 6.63% more returns!
Ardelyx Inc has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Ardelyx Inc, about 38.66% more returns!
Aquestive Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 36.84% more returns!
Anixa Biosciences has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Anixa Biosciences, about 50.46% more returns!
Allogene Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 29.39% more returns!
Akebia Therapeutics has performed better than Seres Therapeutics in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 38.06% more returns!
Seres Therapeutics Technical analysis of indicators
Price action analysis of Seres Therapeutics (MCRB) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Seres Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Seres Therapeutics in short term and the sell signal is strong.
Seres Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Seres Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Seres Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.26 and Seres Therapeutics MCRB stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Seres Therapeutics MCRB stock. Volume based technical analysis of Seres Therapeutics MCRB stock is negative.
Seres Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock MCRB Seres Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MCRB Experts View which covers a lot of information including buying and selling signals
MCRB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Seres Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Seres Therapeutics (MCRB) Technical (Analysis) Reports Seres Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
